Anything is possible. Think of the sentiment. Look at what various other biotech comoanies on asx have done regarding MC increase such as RAP 2c-45c , IIL 16c-1.8$, CYP, BOT, just to name a few and all these companies doing tnat in a short term WITHOUT any income and really only 1 product to offer. Is why i feel IMC will gain a lot in MC due to its pipeline and results NASH results. Travelan increased revenue. So what we have the sentiment is better than ever and much more. Compare it to other biotech MC and i think IMC is in a better partnering, TO, poistion at this stage. With a practical and safe products
IMO
Add to My Watchlist
What is My Watchlist?
